Skip to content
Markets News
Earnings1 min read

CVS lifts 2026 outlook after quarterly revenue rises 5.4%

Makkler Newsroom
November 4, 2026 · Based on reporting by PR Newswire

The healthcare company reported higher third-quarter adjusted earnings and raised its profit and cash flow targets for the full year.

Key takeaways

  • Third-quarter revenue rose 5.4% to $108.4 billion.
  • Adjusted EPS was $2.09, compared with $1.60 a year earlier.
  • CVS raised its 2026 adjusted EPS and operating cash flow guidance.

CVS Health raised its full-year 2026 earnings and cash flow guidance after third-quarter revenue increased 5.4% to $108.4 billion. Adjusted earnings per share were $2.09, up from $1.60 a year earlier.

The company now expects adjusted EPS of at least $8.20, compared with its previous range of $7.90 to $8.10. It raised its operating cash flow outlook to at least $15.5 billion from at least $11.5 billion, and its GAAP diluted EPS outlook to at least $6.98 from a range of $6.84 to $7.04.

CVS said the revised outlook reflects higher results in its Health Care Benefits and Pharmacy & Consumer Wellness segments. It also said it remains cautious about the rest of the year because health care cost trends remain elevated and macroeconomic headwinds are possible.

Third-quarter GAAP diluted EPS was $1.68, versus a loss of $3.13 a year earlier. CVS attributed the improvement primarily to the absence of a $5.7 billion goodwill impairment charge recorded in the prior-year quarter. Adjusted operating income in Health Care Benefits rose to $912 million from $314 million.

As of Wednesday afternoon, CVS shares traded at $80.69, down 11.73% since the previous close.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.